DGNS Dragoneer Growth Opportunities Corporation II

Revenue of $134.1 Million Grows 13.1% Year-Over-Year

Cvent, a market-leading meetings, events, and hospitality technology provider, today announced financial results for the third quarter ended September 30, 2021.

“The digitization of the meetings and events industry that was accelerated by the pandemic has fueled a massive shift in how organizations manage and market their events,” said Reggie Aggarwal, Cvent CEO & Founder. “We have invested heavily over the past 18 months to deliver an integrated live marketing and engagement platform that can be used for nearly any type of event and any delivery mode – whether it’s in-person, virtual, or hybrid. As a result of our investments, we continue to attract new organizations to our platform and expand usage within our current customer base. As we move towards a post pandemic world, we will continue to invest in our people, products, and services and to capture our disproportionate share of this expanding market opportunity.”

Third Quarter 2021 Financial Highlights:

Revenue

• Total revenue was $134.1 million, an increase of 13.1% from the comparable period in 2020, and $4.7 million, or 3.6%, higher than our guidance.
• Event Cloud revenue was $92.5 million, an increase of 27.2% from the comparable period in 2020.
• Hospitality Cloud revenue was $41.6 million, down 9.2% from the comparable period in 2020.

Net Loss and Adjusted EBITDA

• Net loss was $26.1 million compared to $14.4 million in the comparable period in 2020.
• Adjusted EBITDA was $23.4 million, representing an adjusted EBITDA margin of 17.5%, compared to $36.2 million, or an adjusted EBITDA margin of 30.5% in the comparable period in 2020.

Cash, Cash Equivalents and Short-Term Investments

• Cash, cash equivalents and short-term investments at the end of the quarter totaled $118.1 million, compared to $65.3 million as of December 31, 2020.

Business and Operating Highlights:

• In July, Dragoneer Growth Opportunities Corp. II (Nasdaq: DGNS) (“Dragoneer”), a special purpose acquisition company, announced their entry into a definitive business combination agreement (the “Merger Agreement”) with Cvent. The merger is still expected to close in the fourth quarter of 2021. Upon closing, the combined company will operate as Cvent Holding Corp., and is expected to trade under the ticker symbol “CVT.” The transaction values Cvent at an initial enterprise value of $5.3 billion. The transaction will provide Cvent with $801 million in cash (assuming no redemptions of Dragoneer shares are effected), which will enable the company to accelerate product innovation, increase research and development, reduce debt, and expand go-to market activities to capitalize on its leading position in the $30 billion market for in-person, virtual, and hybrid events.

• In August, the Cvent AttendeeHub® - Cvent’s live engagement platform for virtual, in-person, and hybrid events - was selected as the winner of the “Event Management Innovation” award in the fourth annual MarTech Breakthrough Awards. The awards program is conducted by MarTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global marketing, sales, and advertising technology industry today. With more than 2,850 nominations from 17 countries around the world, the win puts Cvent in distinguished company with other market-leading brands including Nielsen, Adobe, and Mailchimp, among others.

• Cvent held its annual Cvent CONNECT® customer conference in August, hosting it for the first time as a hybrid event. In bringing together a live in-person audience in Las Vegas and thousands more from around the world online, attendees were able to experience the power of the Cvent platform first-hand. During the conference, the company introduced several new products and enhancements, including the launch of Cvent Studio, a solution built for virtual event production. Cvent Studio delivers powerful video production capabilities to help organizations create broadcast-quality content for virtual audiences.

Business Outlook

Based on information as of today, November 8, 2021, the Company is issuing the following financial guidance.

Fourth Quarter 2021:

• Revenue is expected to be in the range of $139.9 million to $141.1 million, representing 21.7% year-over-year growth at the mid-point, which is up from our previous guidance of $138.7 million and 20.1% year-over-year growth.
• Adjusted EBITDA is expected to be in the range of $21.8 million to $22.7 million, or 15.9% of revenue at the mid- point.

Full Year 2021:

• Revenue is expected to be in the range of $514.1 million to $515.3 million, representing 3.2% year-over-year growth at the mid-point, which is up from our previous guidance of $507.4 million and 1.7% year-over-year growth.
• Adjusted EBITDA is expected to be in the range of $92.7 million to $93.6 million, or 18.1% of revenue at the mid- point, and is up from our previous guidance of $90.0 million and 17.7% of revenue.

The Company has not reconciled the Adjusted EBITDA forward-looking guidance included in this press release to the most directly comparable GAAP measure because certain items are out of the Company’s control or cannot reasonably be predicted, as the items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. Accordingly, a reconciliation of forward-looking Adjusted EBITDA is not available without unreasonable effort.

Conference Call Information

Cvent’s management team will hold a conference call to discuss third-quarter results today, November 8, 2021 at 6:00 p.m. ET. The conference call can be accessed by dialing 877-705-6003 from the United States and Canada or 201- 493-6725 internationally with conference ID 13724885. A live webcast and replay of the conference call can be accessed from www.dragoneergrowth.com/dgns/. A replay of the call will also be available at www.dragoneergrowth.com/dgns/ after the conclusion of the conference call.

About Cvent

Cvent is a leading meetings, events, and hospitality technology provider with more than 4,000 employees and 200,000 users worldwide. Founded in 1999, the company delivers a comprehensive event marketing and management platform and offers a global marketplace where event professionals collaborate with venues to create engaging, impactful experiences. Cvent is headquartered in Tysons, Virginia, just outside of Washington D.C., and has additional offices around the world to support its growing global customer base. The comprehensive Cvent event marketing and management platform offers software solutions to event organizers and marketers for online event registration, venue selection, event marketing and management, virtual and onsite solutions, and attendee engagement. Cvent’s suite of products automate and simplify the entire event management process and maximize the impact of in-person, virtual, and hybrid events. Hotels and venues use Cvent’s supplier and venue solutions to win more group and corporate travel business through Cvent’s sourcing platforms. Cvent solutions optimize the entire event management value chain and have enabled clients around the world to manage millions of meetings and events. For more information, please visit Cvent.com, or connect with us on Facebook, Twitter or LinkedIn.

Non-GAAP Financial Measures

In this earnings press release and conference call, we use and discuss the following non-GAAP financial measures: Non- GAAP Gross Profit, Non-GAAP Sales & Marketing Expenses, Non-GAAP Research & Development Expenses, Non-GAAP General & Administrative Expenses and Adjusted EBITDA.

We believe that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Cvent’s financial condition and results of operations. We use these non-GAAP measures for financial, operational and budgetary decision-making purposes, and to compare our performance to that of prior periods for trend analyses. We believe that these non-GAAP financial measures provide useful information regarding past financial performance and future prospects, and permit us to more thoroughly analyze key financial metrics used to make operational decisions. We believe that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

We do not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. We urge investors to review the reconciliation of our non-GAAP financial measures to the comparable GAAP financial measures, which are included in this press release, and not to rely on any single financial measure to evaluate our business

Cvent excludes one or more of the following items from these non-GAAP financial measures:

Interest expense. Cvent excludes this expense from its non-GAAP financial measures primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Other income, net. Cvent excludes this item, which is comprised primarily of foreign exchange gains/(losses) and state tax settlements, from its non-GAAP financial measures primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Provision for income taxes. Cvent excludes this item from its non-GAAP financial measures primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Amortization of deferred financing costs and debt discount. Cvent excludes this expense primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Intangible asset amortization. Cvent excludes this expense primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit and Adjusted EBITDA.

Amortization of software development costs. Cvent excludes this expense primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit and Adjusted EBITDA.

Stock-based compensation expense. Cvent excludes this expense primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit, Non-GAAP Sales & Marketing Expenses, Non-GAAP Research & Development Expenses, Non-GAAP General & Administrative Expenses and Adjusted EBITDA.

Cost related to acquisitions. Cost related to acquisitions is comprised of the value of contingent payments included in compensation expense which relate to the potential cash payment to certain employees of acquired companies whose right to receive such payment is forfeited if they terminate their employment prior to the required service period. As the contingent payments are subject to continued employment, GAAP requires that these payments be accounted for as compensation expense and such expense is subject to revaluation. Additionally, cost related to acquisitions includes expenses related to performing due diligence, valuation, earnouts or other acquisition-related activities. Cvent excludes these expenses primarily because they are not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit, Non-GAAP Sales & Marketing Expenses, Non-GAAP Research & Development Expenses, Non-GAAP General & Administrative Expenses and Adjusted EBITDA.

Loss on divestitures. Cvent excludes this expense, which is comprised of the loss on the divestiture of Kapow Events in June 2020, primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Adjusted EBITDA.

Restructuring expenses. Cvent excludes this expense, which is comprised of expenses associated with severance to terminated employees of acquired entities, retention bonuses to employees retained from acquired entities, the global reduction in force that took place in May 2020 in response to the global COVID-19 pandemic, costs to discontinue use of a back-office system and closing of certain office spaces, primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit, Non-GAAP Sales & Marketing Expenses, Non-GAAP Research & Development Expenses, Non-GAAP General & Administrative Expenses and Adjusted EBITDA.

Other items. Cvent excludes this item, which is comprised of certain expenses associated with litigation, private equity management fees, and credit facility fees, and the net of the gain from government subsidies related to the global COVID- 19 pandemic, primarily because it is not considered a part of ongoing operating results when assessing the performance of our business, and Cvent believes that doing so facilitates comparisons to its historical operating results and to the results of other companies in our industry. This adjustment is reflected in Non-GAAP Gross Profit, Non-GAAP Sales & Marketing Expenses, Non-GAAP Research & Development Expenses, Non-GAAP General & Administrative Expenses and Adjusted EBITDA.

Additional Information

In connection with the Business Combination, Dragoneer has filed with the Securities and Exchange Commission (“SEC”) a Registration Statement on Form S-4 (the “Registration Statement”), which includes a preliminary prospectus and preliminary proxy statement. Dragoneer will mail a definitive proxy statement/final prospectus and other relevant documents to its shareholders. This communication is not a substitute for the Registration Statement, the definitive proxy statement/final prospectus or any other document that Dragoneer will send to its shareholders in connection with the Business Combination. The information filed by Dragoneer contains substantially more information about Cvent than is being furnished with this communication and may contain information that an investor will consider important in making a decision regarding an investment in Dragoneer securities. INVESTORS AND SECURITY HOLDERS OF DRAGONEER ARE ADVISED TO READ THE PROXY STATEMENT/PROSPECTUS IN CONNECTION WITH DRAGONEER’S SOLICITATION OF PROXIES FOR ITS EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD TO APPROVE THE BUSINESS COMBINATION (AND RELATED MATTERS), AS WELL AS ANY AMENDMENTS THERETO, AND THE EFFECTIVE REGISTRATION STATEMENT AND DEFINITIVE PROXY STATEMENT/PROSPECTUS, WHEN AVAILABLE, IN CONNECTION WITH SUCH SOLICITATION BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION AND THE PARTIES TO THE BUSINESS COMBINATION. The definitive proxy statement/final prospectus will be mailed to shareholders of Dragoneer as of a record date to be established for voting on the Business Combination. Shareholders will also be able to obtain copies of the proxy statement/prospectus, without charge, once available, at the SEC’s website at www.sec.gov or by directing a request to: Dragoneer Growth Opportunities Corp. II, One Letterman Drive, Building D, Suite M500, San Francisco, California, 94129.

Participants in the Solicitation

Dragoneer, Cvent and certain of their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of Dragoneer’s shareholders in connection with the Business Combination. DRAGONEER’S SHAREHOLDERS AND OTHER INTERESTED PERSONS MAY OBTAIN, WITHOUT CHARGE, MORE DETAILED INFORMATION REGARDING THE DIRECTORS AND OFFICERS OF DRAGONEER IN ITS ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020, WHICH WAS FILED WITH THE SEC ON MARCH 31, 2021 AND IN ITS QUARTERLY REPORTS ON FORM 10-Q FOR THE QUARTERS ENDED MARCH 31, 2021 AND JUNE 30, 2021, WHICH WERE FILED WITH THE SEC ON JUNE 21, 2021 AND AUGUST 16, 2021, RESPECTIVELY. INFORMATION REGARDING THE PERSONS WHO MAY, UNDER SEC RULES, BE DEEMED PARTICIPANTS IN THE SOLICITATION OF PROXIES TO DRAGONEER’S SHAREHOLDERS IN CONNECTION WITH THE PROPOSED TRANSACTION AND OTHER MATTERS TO BE VOTED AT THE SPECIAL MEETING ARE SET FORTH IN THE REGISTRATION STATEMENT FOR THE BUSINESS COMBINATION. Investors and Dragoneer’s shareholders may obtain more detailed information regarding the names and interests in the Business Combination of Dragoneer’s directors and officers in Dragoneer’s filings with the SEC, including the Registration Statement filed with the SEC by Dragoneer, which includes the proxy statement of Dragoneer for the Business Combination, and such information and names of Cvent’s directors and executive officers are also in the Registration Statement filed with the SEC by Dragoneer, which includes the proxy statement of Dragoneer for the Business Combination.

Forward Looking Statements

This communication contains forward-looking statements that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this communication include, but are not limited to, statements regarding future events, such as the proposed Business Combination between Dragoneer and Cvent, including the timing and structure of the transaction, the likelihood and ability of the parties to successfully consummate the Business Combination, the PIPE and the Forward Purchase Agreement, the amount of funds available in the trust account as a result of shareholder redemptions or otherwise, as well as statements about the composition of the board of directors of the company. We cannot assure you that the forward-looking statements in this communication will prove to be accurate. These forward looking statements are subject to a number of risks and uncertainties, including, among others, the general economic, political, business and competitive conditions; the inability of the parties to consummate the Business Combination or the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement or any related agreements or could otherwise cause the transaction to fail to close; the outcome of any legal proceedings that may be instituted against the parties following the announcement of the Business Combination and the transactions contemplated by the Business Combination; the ability of existing investors to redeem the ability to complete the Business Combination due to the failure to obtain approval from Dragoneer’s shareholders, or the risk that the approval of the shareholders of Dragoneer for the potential transaction is otherwise not obtained; the failure to satisfy other closing conditions in the Business Combination Agreement or otherwise, the occurrence of any event that could give rise to the termination of the Business Combination Agreement; the failure to obtain financing to complete the Business Combination, including to consummate the PIPE or the transactions contemplated by the Forward Purchase Agreement; the ability to recognize the anticipated benefits of the Business Combination; the impact of COVID-19 on Cvent’s business and/or the ability of the parties to complete the Business Combination; the receipt of an unsolicited offer from another party for an alternative business transaction that could interfere with the Business Combination; changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; failure to realize the anticipated benefits of the Business Combination, including as a result of a delay in consummating the potential transaction or difficulty in integrating the businesses of Dragoneer and Cvent; the risk that the Business Combination disrupts current plans and operations of Dragoneer or Cvent as a result of the announcement and consummation of the Business Combination; the ability of the Company to grow and manage growth profitably and retain its key employees; the inability to obtain or maintain the listing of the post-acquisition company’s securities on Nasdaq following the Business Combination; changes in applicable laws or regulations and delays in obtaining, adverse conditions contained in, or the inability to obtain regulatory approvals required to complete the Business Combination; costs related to the Business Combination; and other risks and uncertainties, including those to be included under the header “Risk Factors” in the registration statement on Form S-4 filed by Dragoneer with the SEC, those included under the header “Risk Factors” in the final prospectus of Dragoneer related to its initial public offering and those under the heading “Summary Risk Factors” in the investor presentation filed as Exhibit 99.3 to Dragoneer’s Current Report on Form 8-K filed on July 23, 2021. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not rely on these statements in making an investment decision or regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this communication represent our views as of the date of this communication. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this communication.

Disclaimer

This communication is for informational purposes only and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities or the solicitation of any vote in any jurisdiction pursuant to the Business Combination or otherwise, nor shall there be any sale, issuance or transfer or securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE PROPOSED TRANSACTIONS OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

(unaudited)

 

Assets

September 30, 2021

 

December 31, 2020

Current Assets:

 

 

 

Cash and cash equivalents

$

115,406

 

 

$

65,265

 

Restricted cash

 

103

 

 

 

205

 

Short-term investments

 

2,696

 

 

—

 

Accounts receivable, net of allowance of $3.0 million and $3.3 million, respectively

 

82,651

 

 

 

141,113

 

Capitalized commission, net

 

22,142

 

 

 

22,000

 

Prepaid expenses and other current assets

 

15,934

 

 

 

12,415

 

Total current assets

 

238,932

 

 

 

240,998

 

Property and equipment, net

 

16,024

 

 

 

21,715

 

Capitalized software development costs, net

 

113,519

 

 

 

124,030

 

Intangible assets, net

 

234,160

 

 

 

272,416

 

Goodwill

 

1,617,936

 

 

 

1,605,628

 

Operating lease-right-of-use assets

 

29,031

 

 

 

38,922

 

Capitalized commission, net, non-current

 

19,275

 

 

 

20,427

 

Deferred tax assets, non-current

 

1,999

 

 

 

2,036

 

Other assets, non-current, net

 

3,997

 

 

 

5,479

 

Total assets

$

2,274,873

 

 

$

2,331,651

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Current portion of long-term debt

$

4,546

 

 

$

17,920

 

Accounts payable

 

2,316

 

 

 

4,078

 

Accrued expenses and other current liabilities

 

69,865

 

 

 

81,939

 

Fees payable to customers

 

30,750

 

 

 

16,872

 

Operating lease liabilities, current

 

11,459

 

 

 

15,910

 

Deferred revenue

 

226,307

 

 

 

207,622

 

Total current liabilities

 

345,243

 

 

 

344,341

 

Deferred tax liabilities, non-current

 

18,226

 

 

 

16,950

 

Long-term debt, net

 

750,540

 

 

 

753,953

 

Operating lease liabilities, non-current

 

32,036

 

 

 

40,317

 

Other liabilities, non-current

 

7,651

 

 

 

5,239

 

Total liabilities

1,153,696

1,160,800

Commitments and contingencies

(Note 13) Stockholders’ equity:

Common stock, $0.001 par value, 1,100,000 shares authorized at September 30, 2021,

and December 31, 2020; 917,761 and 917,365 shares issued and outstanding as of September 30,

2021 and December 31, 2020, respectively

 

1

 

 

1

 

Additional paid-in capital

 

1,953,654

 

 

1,936,447

 

Accumulated other comprehensive loss

 

(2,415

)

 

(69

)

Accumulated deficit

 

(830,063

)

 

(765,528

)

Total stockholders’ equity

 

1,121,177

 

 

1,170,851

 

Total liabilities and stockholders’ equity

$

2,274,873

 

$

2,331,651

 

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(in thousands, except share and per share data)

(unaudited)

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2021

 

2020

 

2021

 

2020

Revenue

$

134,058

 

$

118,507

 

$

374,159

 

$

383,216

 

Cost of revenue

 

50,635

 

 

39,888

 

 

140,479

 

 

134,334

 

Gross profit

 

83,423

 

 

78,619

 

 

233,680

 

 

248,882

 

Operating expenses:

 

 

 

 

Sales and marketing

 

37,161

 

 

29,004

 

 

99,069

 

 

99,543

 

Research and development

 

25,685

 

 

20,970

 

 

72,016

 

 

68,992

 

General and administrative

 

25,358

 

 

20,243

 

 

63,711

 

 

63,881

 

Intangible asset amortization, exclusive of amounts included in cost of revenue

 

12,757

 

 

13,491

 

 

38,721

 

 

40,416

 

 

Total operating expenses

 

100,961

 

 

83,708

 

 

273,517

 

 

272,832

 

Loss from operations

 

(17,538

)

 

(5,089

)

 

(39,837

)

 

(23,950

)

Interest expense

 

(7,546

)

 

(8,151

)

 

(22,717

)

 

(27,695

)

Amortization of deferred financing costs and debt discount

 

(938

)

 

(948

)

 

(2,823

)

 

(2,852

)

Loss on divestitures, net

 

-

 

 

-

 

 

-

 

 

(9,634

)

Other income, net

 

1,864

 

 

461

 

 

6,135

 

 

1,919

 

Loss before income taxes

 

(24,158

)

 

(13,727

)

 

(59,242

)

 

(62,212

)

Provision for income taxes

 

1,968

 

 

648

 

 

5,294

 

 

4,870

 

Net loss

 

(26,126

)

 

(14,375

)

 

(64,536

)

 

(67,082

)

Other comprehensive loss:

 

 

 

 

Foreign currency translation gain/(loss)

 

(2,002

)

 

2,207

 

 

(2,314

)

 

(1,504

)

Comprehensive loss

$

(28,128

)

$

(12,168

)

$

(66,850

)

$

(68,586

)

Basic and Diluted net loss per common share

$

(27.93

)

$

(15,67

)

$

(69.87

)

$

(73.15

)

Basic and Diluted weighted-average common shares outstanding

 

935,522

 

 

917,085

 

 

923,626

 

 

917,082

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, except share data) (unaudited)

 

Nine Months Ended

September 30,

 

 

2021

 

 

 

2020

 

Operating activities:

 

 

 

Net loss

$

(64,536

)

 

$

(67,082

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

Depreciation and amortization

 

93,142

 

 

 

96,217

 

Amortization of the right-of-use assets

 

6,817

 

 

 

8,063

 

Allowance for expected credit losses, net

 

5.549

 

 

 

663

 

Amortization of deferred financing costs and debt discount

 

2,823

 

 

 

2,852

 

Amortization of capitalized commission

 

21,568

 

 

 

22,117

 

Unrealized foreign currency transaction gain

 

19

 

 

 

87

 

Stock-based compensation

 

16,811

 

 

 

14,557

 

Loss on divestiture

 

-

 

 

 

9,634

 

Change in deferred taxes

 

1,313

 

 

 

1,228

 

Change in operating assets and liabilities, net of acquired assets and liabilities:

 

 

 

Accounts receivable

 

52,611

 

 

 

32,395

 

Prepaid expenses and other assets

 

(6,064

)

 

 

481

 

Capitalized commission, net

 

(26,706

)

 

 

(22,894

)

Accounts payable, accrued expenses and other liabilities

 

8,999

 

 

 

(18,275

)

Operating lease liability

 

(9,666

)

 

 

(7,066

)

Deferred revenue

 

18,878

 

 

 

(19,147

)

Net cash provided by operating activities

 

121,558

 

 

 

53,830

 

Investing activities:

 

 

 

Purchase of property and equipment

 

(2,768

)

 

 

(1,298

)

Capitalized software development costs

 

(30,272

)

 

 

(32,425

)

Purchase of short-term investments

 

(31,435

)

 

 

(26,914

)

Maturities of short-term investments

 

28,739

 

 

 

26,268

 

Proceeds from divestiture

 

122

 

 

 

500

 

Acquisitions, net of cash acquired

 

(14,769

)

 

 

(1,400

)

Net cash used in investing activities

 

(50,383

)

 

 

(35,269

)

Financing activities:

 

 

 

Principal repayments on first lien term loan

 

(5,951

)

 

 

(5,951

)

Principal repayments of revolving credit facility

 

(13,400

)

 

 

(26,100

)

Proceeds from revolving credit facility

 

-

 

 

 

40,000

 

Proceeds from exercise of stock options

 

522

 

 

 

5

 

Repurchase of stock

 

(57

)

 

 

-

 

Net cash provided by financing activities

 

(18,886

)

 

 

7,954

 

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

(2,250

)

 

 

(1,471

)

Change in cash, cash equivalents, and restricted cash

 

50,039

 

 

 

25,044

 

Cash, cash equivalents, and restricted cash, beginning of period

 

65,470

 

 

 

72,721

 

Cash, cash equivalents, and restricted cash, end of period

 

115,509

 

 

 

97,765

 

Supplemental cash flow information:

 

 

 

Interest paid

 

22,721

 

 

 

27,682

 

Income taxes paid

 

4,655

 

 

 

4,564

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

Outstanding payments for purchase of property and equipment at period end

 

331

 

 

 

462

 

Outstanding payments for capitalized software development costs at period end

 

513

 

 

 

322

 

RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES

(in thousands, except share amounts and share counts) (unaudited)

 

 

Three Months Ended

September 30,

Nine Months Ended

September 30,

 

2021

 

2020

 

 

2021

 

2020

Non-GAAP Gross Profit:

 

 

 

 

 

Gross profit

$

83,423

 

 

$

78,619

 

 

$

233,680

 

$

248,882

 

Adjustments

Depreciation

 

759

 

 

 

1,338

 

 

 

2,771

 

 

4,280

 

Amortization of software development costs

 

15,508

 

 

 

15,154

 

 

 

45,737

 

 

43,533

 

Intangible asset amortization

 

-

 

 

 

111

 

 

 

180

 

 

326

 

Stock-based compensation expense

 

456

 

 

 

157

 

 

 

950

 

 

466

 

Restructuring expense

 

9

 

 

 

(98

)

 

 

11

 

 

1,240

 

Cost related to acquisitions

 

11

 

 

 

1

 

 

 

11

 

 

19

 

Other items

 

-

 

 

 

-

 

 

 

(994

)

 

41

 

Non-GAAP gross profit

$

100,166

 

 

$

95,282

 

 

$

282,346

 

$

298,787

 

Gross Margin:

 

 

 

 

 

 

Revenue

$

134,058

 

 

$

118,507

 

 

$

374,159

 

$

383,216

 

Gross margin

 

62.2

%

 

 

66.3

%

 

 

62.5

%

 

64.9

%

Non-GAAP gross margin

 

74.7

%

 

 

80.4

%

 

 

75.5

%

 

78.0

%

 

Three Months Ended

September 30,

Nine Months Ended

September 30,

 

2021

2020

2021

2020

Non-GAAP Sales & Marketing Expenses:

 

 

 

 

Sales & marketing

$

37,161

 

$

29,004

 

$

99,069

 

$

99,543

 

Adjustments

 

 

 

 

Depreciation

 

(283

)

 

(636

)

 

(1,132

)

 

(2,080

)

Stock-based compensation expense

 

(2,578

)

 

(1,397

)

 

(5,371

)

 

(4,162

)

Restructuring expense

 

(41

)

 

107

 

 

(72

)

 

(830

)

Cost related to acquisitions

 

(52

)

 

(40

)

 

(117

)

 

(194

)

Other items

 

1

 

 

(151

)

 

380

 

 

(151

)

Non-GAAP sales & marketing expenses

$

34,208

 

$

26,887

 

$

92,757

 

$

92,126

 

Sales & Marketing Expenses as a Percent of Revenue:

 

 

 

 

Revenue

$

134,058

 

$

118,507

 

$

374,159

 

$

383,216

 

Sales & marketing expenses

 

27.7

%

 

24.5

%

 

26.5

%

 

26.0

%

Non-GAAP sales & marketing expenses

 

25.5

%

 

22.7

%

 

24.8

%

 

24.0

%

 

Three Months Ended

September 30,

Nine Months Ended

September 30,

 

2021

2020

2021

2020

Non-GAAP Research & Development

Expenses:

 

 

 

 

Research & development

$

25,685

 

$

20,970

 

$

72,016

 

$

68,992

 

Adjustments

 

 

 

 

Depreciation

 

(409

)

 

(714

)

 

(1,431

)

 

(2,163

)

Stock-based compensation expense

 

(2,183

)

 

(1,125

)

 

(4,321

)

 

(3,377

)

Restructuring expense

 

(52

)

 

30

 

 

(67

)

 

(832

)

Cost related to acquisitions

 

-

 

 

(18

)

 

(9

)

 

(234

)

Other items

 

-

 

 

-

 

 

3,366

 

 

-

 

Non-GAAP Research & development expenses

$

23,041

 

$

19,143

 

$

69,554

$

62,386

Research & Development Expenses as a

Percent of Revenue:

 

 

 

 

Revenue

$

134,058

 

$

118,507

 

$

374,159

 

$

383,216

 

Research & development expenses

 

19.2

%

 

17.7

%

 

19.2

%

 

18.0

%

Non-GAAP research & development expenses

 

17.2

%

 

16.2

%

 

18.6

%

 

16.3

%

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2021

 

2020

 

2021

 

2020

Non-GAAP General & Administrative

Expenses:

 

 

 

 

 

General & administrative

$

25,359

 

$

20,243

 

 

$

63,711

 

$

63,881

 

Adjustments

 

 

 

 

 

Depreciation

 

(1,041

)

 

(1,010

)

 

 

(3,143

)

 

(3,443

)

Stock-based compensation expense

 

(3,170

)

 

(2,200

)

 

 

(6,169

)

 

(6,552

)

Restructuring expense

 

(1,109

)

 

(2,868

)

 

 

(1,627

)

 

(3,666

)

Cost related to acquisitions

 

4

 

 

(54

)

 

 

(1,107

)

 

(342

)

Other items

 

(548

)

 

(1,013

)

 

 

(2,485

)

 

(4,251

)

Non-GAAP general & administrative expenses

$

19,495

 

$

13,098

 

$

49,180

 

$

45,627

 

General & Administrative Expenses as a Percent of Revenue:

 

 

 

 

 

Revenue

$

134,058

 

$

118,507

 

 

$

374,159

 

$

383,216

 

General & administrative expenses

 

18.9

%

 

17.1

%

 

 

17.0

%

 

16.7

%

Non-GAAP general & administrative expenses

 

14.5

%

 

11.1

%

 

 

13.1

%

 

11.9

%

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

2021

 

2020

 

2021

2020

Adjusted EBITDA:

 

 

 

 

 

 

Net loss

$

(26,126

)

 

$

(14,375

)

 

$

(64,536

)

$

(67,082

)

Adjustments

 

 

 

 

 

 

Interest expense

 

7,546

 

 

 

8,151

 

 

 

22,717

 

 

27,695

 

Amortization of deferred financing costs and debt discount

 

 

 

938

 

 

 

 

 

 

948

 

 

 

 

 

 

2,823

 

 

 

 

 

2,852

 

 

Loss on divestitures, net

 

-

 

 

 

-

 

 

 

-

 

 

9,634

 

Other income, net

 

(1,864

)

 

 

(461

)

 

 

(6,135

)

 

(1,919

)

Provision for income taxes

 

1,968

 

 

 

648

 

 

 

5,294

 

 

4,870

 

Depreciation

 

2,493

 

 

 

3,698

 

 

 

8,478

 

 

11,966

 

Amortization of software development costs

 

15,508

 

 

 

15,266

 

 

 

45,917

 

 

43,860

 

Intangible asset amortization

 

12,757

 

 

 

13,491

 

 

 

38,721

 

 

40,416

 

Stock-based compensation expense

 

8,387

 

 

 

4,879

 

 

 

16,811

 

 

14,557

 

Restructuring expense

 

1,212

 

 

 

2,634

 

 

 

1,777

 

 

6,568

 

Cost related to acquisitions

 

60

 

 

 

112

 

 

 

1,245

 

 

788

 

Other items

 

544

 

 

 

1,162

 

 

 

(2,256

)

 

4,441

 

Adjusted EBITDA

$

23,423

 

 

$

36,153

 

 

$

70,856

 

$

98,646

 

Adjusted EBITDA Margin:

 

 

 

 

 

 

Revenue

$

134,058

 

 

$

118,507

 

 

$

374,159

 

$

383,216

 

Net loss margin

 

(19.5

)%

 

 

(12.1

)%

 

 

(17.2

)%

 

(17.5

)%

Adjusted EBITDA margin

 

17.5

%

 

 

30.5

%

 

 

18.9

%

 

25.7

%

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20211108006097/en/

Investor Relations April Scee, ICR April.Scee@icrinc.com (646) 277-1219

Media Relations Erica Stoltenberg estoltenberg@cvent.com (571) 378-6240